• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对超重乳腺癌幸存者的淋巴水肿:饮食与运动干预的一项初步随机对照试验

Targeting Lymphedema in Overweight Breast Cancer Survivors: A Pilot Randomized Controlled Trial of Diet and Exercise Intervention.

作者信息

Ruiz-Molina Yolanda, Padial Marina, Martín-Bravo María Del Mar, García-Olivares María, Porras Nuria, Chicharro Alejandro, Mora-Robles Javier, González-Jiménez Andrés, Sasso Corina Verónica, Olveira Gabriel

机构信息

Servicio de Medicina Física y Rehabilitación, Hospital Virgen de la Victoria, 29010 Malaga, Spain.

Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Malaga, Spain.

出版信息

Nutrients. 2025 Aug 27;17(17):2768. doi: 10.3390/nu17172768.

DOI:10.3390/nu17172768
PMID:40944158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12430713/
Abstract

: Breast cancer-related lymphedema (BCRL) is more prevalent and severe in women with overweight or obesity. This study evaluated the effect of a comprehensive lifestyle intervention-comprising supervised exercise, a hypocaloric Mediterranean diet, and optional meal replacement-on lymphedema outcomes in this population. : In this pilot randomized controlled trial, 112 women with BCRL and BMI 25-40 kg/m were assigned to an intervention group-receiving supervised resistance and aerobic training, dietary counseling, and optional high-protein meal replacement-or to a control group with standard advice. The primary outcome was change in affected limb volume at 3 and 6 months. Secondary outcomes included morphofunctional parameters, muscle strength, dietary intake, and serum levels of cytokines (IL-1β, IL-6, IL-10, and TNF-α). Analyses also explored outcomes according to whether participants achieved ≥ 5% weight loss. : Ninety-four participants completed the trial (intervention n = 43, control n = 51). At 6 months, women who achieved ≥5% weight loss had greater reductions in affected limb volume (-664.9 ± 362.1 mL vs. -395.6 ± 596.9 mL). The intervention group showed significantly greater improvements in BMI (-1.14 ± 1.22 kg/m), waist circumference (-3.59 ± 4.6 cm), triceps skinfold (-4.61 ± 3.02 mm), fat mass (-2.38 ± 2.75 kg), extracellular water (-0.58 ± 0.85 L), and quadriceps strength (+7.1 ± 9.7 kg). No significant changes were observed in circulating cytokines. : In this pilot randomized controlled trial, a structured dietary and exercise intervention improved morphofunctional outcomes in overweight women with BCRL. Weight loss of ≥5% emerged as a potentially relevant therapeutic target that may inform the design of future studies aimed at optimizing lymphedema management.

摘要

乳腺癌相关淋巴水肿(BCRL)在超重或肥胖女性中更为普遍且严重。本研究评估了一项综合生活方式干预措施(包括监督下的运动、低热量地中海饮食以及可选的代餐)对该人群淋巴水肿结局的影响。

在这项先导性随机对照试验中,112名BCRL且体重指数(BMI)为25 - 40kg/m²的女性被分配至干预组(接受监督下的抗阻和有氧运动训练、饮食咨询以及可选的高蛋白代餐)或接受标准建议的对照组。主要结局是3个月和6个月时患侧肢体体积的变化。次要结局包括形态功能参数、肌肉力量、饮食摄入量以及细胞因子(白细胞介素-1β、白细胞介素-6、白细胞介素-10和肿瘤坏死因子-α)的血清水平。分析还根据参与者是否实现≥5%的体重减轻来探究结局。

94名参与者完成了试验(干预组n = 43,对照组n = 51)。在6个月时,体重减轻≥5%的女性患侧肢体体积的减少幅度更大(-664.9±362.1mL对-395.6±596.9mL)。干预组在BMI(-1.14±1.22kg/m²)、腰围(-3.59±4.6cm)、肱三头肌皮褶厚度(-4.61±3.02mm)、脂肪量(-2.38±2.75kg)、细胞外液(-0.58±0.85L)和股四头肌力量(+7.1±9.7kg)方面有显著更大的改善。循环细胞因子未观察到显著变化。

在这项先导性随机对照试验中,结构化的饮食和运动干预改善了超重BCRL女性的形态功能结局。体重减轻≥5%成为一个潜在相关的治疗靶点,可能为未来旨在优化淋巴水肿管理的研究设计提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/12430713/d80fa7f57a95/nutrients-17-02768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/12430713/d80fa7f57a95/nutrients-17-02768-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/12430713/d80fa7f57a95/nutrients-17-02768-g001.jpg

相似文献

1
Targeting Lymphedema in Overweight Breast Cancer Survivors: A Pilot Randomized Controlled Trial of Diet and Exercise Intervention.针对超重乳腺癌幸存者的淋巴水肿:饮食与运动干预的一项初步随机对照试验
Nutrients. 2025 Aug 27;17(17):2768. doi: 10.3390/nu17172768.
2
Manual lymphatic drainage for lymphedema following breast cancer treatment.乳腺癌治疗后淋巴水肿的手法淋巴引流
Cochrane Database Syst Rev. 2015 May 21;2015(5):CD003475. doi: 10.1002/14651858.CD003475.pub2.
3
Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity.移动健康(m-health)智能手机干预措施用于超重或肥胖的青少年和成年人。
Cochrane Database Syst Rev. 2024 Feb 20;2(2):CD013591. doi: 10.1002/14651858.CD013591.pub2.
4
Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy.针对乳腺癌治疗后有发生淋巴水肿风险的患者,预防临床上可检测到的上肢淋巴水肿的保守干预措施。
Cochrane Database Syst Rev. 2015 Feb 13;2015(2):CD009765. doi: 10.1002/14651858.CD009765.pub2.
5
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
6
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
7
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.肥胖症减肥干预措施以提高子宫内膜癌女性的生存率。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3.
8
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
9
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.替尔泊肽10毫克和15毫克与司美格鲁肽2.4毫克治疗2型糖尿病患者肥胖和超重的间接比较疗效与安全性
Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16508.
10
Combined Aerobic and Resistance Training Improves Body Composition, Alters Cardiometabolic Risk, and Ameliorates Cancer-Related Indicators in Breast Cancer Patients and Survivors with Overweight/Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.有氧运动和抗阻训练联合改善超重/肥胖乳腺癌患者和幸存者的身体成分、改变心血管代谢风险,并改善与癌症相关的指标:随机对照试验的系统评价和荟萃分析。
J Sports Sci Med. 2024 Jun 1;23(2):366-395. doi: 10.52082/jssm.2024.366. eCollection 2024 Jun.

本文引用的文献

1
Molecular pathophysiology of secondary lymphedema.继发性淋巴水肿的分子病理生理学
Front Cell Dev Biol. 2024 Jul 8;12:1363811. doi: 10.3389/fcell.2024.1363811. eCollection 2024.
2
Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.定义乳腺癌相关淋巴水肿(BCRL)的患病率和风险因素:淋巴水肿监测的实用方法。
Ann Acad Med Singap. 2024 Feb 28;53(2):80-89. doi: 10.47102/annals-acadmedsg.2023264.
3
The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention.
炎症在淋巴水肿中的作用:发病机制的叙述性综述及治疗干预的机会。
Int J Mol Sci. 2024 Mar 31;25(7):3907. doi: 10.3390/ijms25073907.
4
Cardiovascular Disease and the Mediterranean Diet: Insights into Sex-Specific Responses.心血管疾病与地中海饮食:对性别特异性反应的深入了解。
Nutrients. 2024 Feb 19;16(4):570. doi: 10.3390/nu16040570.
5
Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.体重指数增加术后6至18个月患乳腺癌相关淋巴水肿的风险:一项回顾性研究。
Support Care Cancer. 2023 Apr 19;31(5):278. doi: 10.1007/s00520-023-07721-7.
6
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options.我们对治疗乳腺癌相关性淋巴水肿有哪些了解?对治疗选择的现有知识进行综述。
Breast Cancer. 2023 Mar;30(2):187-199. doi: 10.1007/s12282-022-01428-z. Epub 2022 Dec 26.
7
Role of weight lost in breast cancer-related lymph.体重减轻在乳腺癌相关淋巴方面的作用
Rehabilitacion (Madr). 2023 Apr-Jun;57(2):100763. doi: 10.1016/j.rh.2022.10.002. Epub 2022 Nov 10.
8
Burden of lymphedema in long-term breast cancer survivors by race and age.按种族和年龄划分的长期乳腺癌幸存者的淋巴水肿负担。
Cancer. 2022 Dec 1;128(23):4119-4128. doi: 10.1002/cncr.34489. Epub 2022 Oct 12.
9
Meal Replacements for Weight-Related Complications in Type 2 Diabetes: What Is the State of the Evidence?用于 2 型糖尿病相关并发症的代餐:证据现状如何?
Front Endocrinol (Lausanne). 2022 Jul 28;13:875535. doi: 10.3389/fendo.2022.875535. eCollection 2022.
10
Benefits of Dietary Management in Breast Cancer Patients: A Systematic Review and Meta-Analysis.膳食管理对乳腺癌患者的益处:系统评价和荟萃分析。
Nutr Cancer. 2022;74(5):1580-1592. doi: 10.1080/01635581.2021.1957129. Epub 2021 Jul 28.